Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

Author:

van Duin David1,Lok Judith J2,Earley Michelle2,Cober Eric3,Richter Sandra S4,Perez Federico56,Salata Robert A6,Kalayjian Robert C7,Watkins Richard R89,Doi Yohei10,Kaye Keith S11,Fowler Vance G1213,Paterson David L14,Bonomo Robert A561516,Evans Scott2,

Affiliation:

1. Division of Infectious Diseases, University of North Carolina, Chapel Hill

2. Department of Biostatistics and the Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts

3. Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio

4. Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio

5. Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio

6. Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio

7. Department of Medicine, MetroHealth Medical Center, Cleveland, Ohio

8. Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, Ohio

9. Division of Infectious Diseases, Cleveland Clinic Akron General, Ohio

10. Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pennsylvania

11. Division of Infectious Diseases, University of Michigan, Ann Arbor

12. Duke Clinical Research Institute, Duke University, Durham, North Carolina

13. Division of Infectious Diseases, Duke University, Durham, North Carolina

14. University of Queensland Centre for Clinical Research, Royal Brisbane and Women’s Hospital Campus, Australia

15. Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio

16. Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3